Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement



 NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance
                          with Bid Price Requirement

PR Newswire

HANGZHOU, China, Nov. 12, 2013

HANGZHOU, China, Nov. 12, 2013 /PRNewswire/ -- China Jo-Jo Drugstores, Inc.
(NASDAQ:CJJD) (the "Company"), a retail and wholesale distributor of
pharmaceutical and other healthcare products in China, today announced that on
November 6, 2013, it received notification from NASDAQ granting the Company an
additional 180-day period, or until May 5, 2014, to remain listed on the
NASDAQ Capital Market and to regain compliance with NASDAQ's minimum $1.00 bid
price per share rule.

Under NASDAQ Listing Rules, the Company was granted this extension because it
met the continued listing requirement for market value of publicly held shares
and all other applicable NASDAQ listing requirements, except the bid price
requirement. The Company provided written notice to NASDAQ of its intention to
cure the bid price deficiency during the second compliance period by affecting
a reverse stock split, if necessary.

The Company will regain compliance with the minimum bid requirement if at any
time prior to May 5, 2014, the bid price for the Company's common stock closes
at $1.00 per share or above for a minimum of 10 consecutive business days.

If the Company does not regain compliance by the end of this extension period,
it will receive notification from NASDAQ that its shares are subject to
delisting. At that point, the Company may then appeal the delisting
determination to a NASDAQ Hearings Panel.

About China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc., through its subsidiaries and contractually
controlled affiliates, is a retailer and wholesale distributor of
pharmaceutical and other healthcare products in the People's Republic of
China. As of September 30, 2013, the Company had 51 retail pharmacies
throughout Zhejiang Province and Shanghai.

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: Certain of the statements made in the press release constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements can be identified by the use
of forward-looking terminology such as "believe," "expect," "may," "will,"
"should," "project," "plan," "seek," "intend," or "anticipate" or the negative
thereof or comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
the progress of new product development. Actual results could differ
materially from the expectations reflected in such forward-looking statements
as a result of a variety of factors, including the risks associated with the
effect of changing economic conditions in The People's Republic of China,
variations in cash flow, reliance on collaborative retail partners and on new
product development, variations in new product development, risks associated
with rapid technological change, and the potential of introduced or undetected
flaws and defects in products, and other risk factors detailed in reports
filed with the Securities and Exchange Commission from time to time.

SOURCE China Jo-Jo Drugstores, Inc.

Contact: China Jo-Jo Drugstores, Inc.?, Ming Zhao, Chief Financial Officer?,
Tel: (561) 372-5555?, Email: frank.zhao@jojodrugstores.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement